Ekström L - Search Results

1

Radical prostatectomy: influence on serum and urinary androgen levels.

Olsson M, Ekström L, Schulze J, Kjellman A, Akre O, Rane A, Gustafsson O. Olsson M, et al. Among authors: ekstrom l. Prostate. 2010 Feb 1;70(2):200-5. doi: 10.1002/pros.21053. Prostate. 2010. PMID: 19760638

2

A functional C-G polymorphism in the CYP7B1 promoter region and its different distribution in Orientals and Caucasians.

Jakobsson J, Karypidis H, Johansson JE, Roh HK, Rane A, Ekström L. Jakobsson J, et al. Among authors: ekstrom l. Pharmacogenomics J. 2004;4(4):245-50. doi: 10.1038/sj.tpj.6500236. Pharmacogenomics J. 2004. PMID: 15007371

3

Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism.

Jakobsson J, Ekström L, Inotsume N, Garle M, Lorentzon M, Ohlsson C, Roh HK, Carlström K, Rane A. Jakobsson J, et al. Among authors: ekstrom l. J Clin Endocrinol Metab. 2006 Feb;91(2):687-93. doi: 10.1210/jc.2005-1643. Epub 2005 Dec 6. J Clin Endocrinol Metab. 2006. PMID: 16332934

4

A novel polymorphism in the 17beta-hydroxysteroid dehydrogenase type 5 (aldo-keto reductase 1C3) gene is associated with lower serum testosterone levels in caucasian men.

Jakobsson J, Palonek E, Lorentzon M, Ohlsson C, Rane A, Ekström L. Jakobsson J, et al. Among authors: ekstrom l. Pharmacogenomics J. 2007 Aug;7(4):282-9. doi: 10.1038/sj.tpj.6500419. Epub 2006 Sep 19. Pharmacogenomics J. 2007. PMID: 16983398

5

Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate.

Karypidis AH, Olsson M, Andersson SO, Rane A, Ekström L. Karypidis AH, et al. Among authors: ekstrom l. Pharmacogenomics J. 2008 Apr;8(2):147-51. doi: 10.1038/sj.tpj.6500449. Epub 2007 Mar 27. Pharmacogenomics J. 2008. PMID: 17387331

6

Regulation and expression of human CYP7B1 in prostate: overexpression of CYP7B1 during progression of prostatic adenocarcinoma.

Olsson M, Gustafsson O, Skogastierna C, Tolf A, Rietz BD, Morfin R, Rane A, Ekström L. Olsson M, et al. Among authors: ekstrom l. Prostate. 2007 Sep 15;67(13):1439-46. doi: 10.1002/pros.20630. Prostate. 2007. PMID: 17639508

7

The UGT2B17 gene deletion is not associated with prostate cancer risk.

Olsson M, Lindström S, Häggkvist B, Adami HO, Bälter K, Stattin P, Ask B, Rane A, Ekström L, Grönberg H. Olsson M, et al. Among authors: ekstrom l. Prostate. 2008 Apr 1;68(5):571-5. doi: 10.1002/pros.20700. Prostate. 2008. PMID: 18247404

8

Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation.

Schulze JJ, Lundmark J, Garle M, Skilving I, Ekström L, Rane A. Schulze JJ, et al. Among authors: ekstrom l. J Clin Endocrinol Metab. 2008 Jul;93(7):2500-6. doi: 10.1210/jc.2008-0218. Epub 2008 Mar 11. J Clin Endocrinol Metab. 2008. PMID: 18334593

9

Genetic aspects of epitestosterone formation and androgen disposition: influence of polymorphisms in CYP17 and UGT2B enzymes.

Schulze JJ, Lorentzon M, Ohlsson C, Lundmark J, Roh HK, Rane A, Ekström L. Schulze JJ, et al. Among authors: ekstrom l. Pharmacogenet Genomics. 2008 Jun;18(6):477-85. doi: 10.1097/FPC.0b013e3282fad38a. Pharmacogenet Genomics. 2008. PMID: 18496127

10

Substantial advantage of a combined Bayesian and genotyping approach in testosterone doping tests.

Schulze JJ, Lundmark J, Garle M, Ekström L, Sottas PE, Rane A. Schulze JJ, et al. Among authors: ekstrom l. Steroids. 2009 Mar;74(3):365-8. doi: 10.1016/j.steroids.2008.11.003. Epub 2008 Nov 13. Steroids. 2009. PMID: 19056415

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

232 results

Search Page

Filters